biorasi Blogs
-
Unflattening The Curve: Minimize The Impact To Patients Who Depend On Your Successful Clinical Trial
4/21/2021
Similar to how the response and immediate action to the “Flattening the Curve” movement in 2020 was executed to dramatically lessen the severity and impact of the pandemic on millions of lives, the actions and strategies implemented in today’s clinical studies will impact how patients in current trials will get their investigational treatments. Without a proactive and comprehensive strategy in place to manage clinical trials during the pandemic, consequences may be severe –especially for those that need the treatment the most.
-
Keep It Simple: The Top 5 Steps For Successful Protocol Design
4/21/2021
Starting clinical trials in the right direction begins with a well-designed study protocol – the more comprehensive, the better. In this article we discuss some of the more “common sense” best practices to consider during the protocol design process with Dr. Robert Wilkins, former PI and Founder of QPS Consulting.
-
Patient Recruitment Solutions: Optimizing Social Strategies For Clinical Studies
4/21/2021
Quicker recruitment means more than just a boost of speed. Biorasi has built our reputation as a fast and flexible leader for CRO solutions, and we are constantly striving to find more innovative and efficient methods for enrollment – inclusive of social media strategies.
-
The Power of Patient Registries - How To Collaborate With Patients To Enhance Orphan Drug Research
6/11/2019
Patient registries assist orphan drug development by giving manufacturers access to clinical, genetic, and biological data from a large patient population. Using registries, sponsors can better understand the disease, its history, and patients’ needs, all of which benefit clinical trial design and effectiveness.
-
What To Look for When Selecting A Risk-Based Monitoring Partner
5/22/2019
There are no concrete instructions when it comes to RBM, and planning a successful RBM design can be challenging. Even so, we believe investing in an experienced partner to help you with RBM design is worthwhile. RBM can be an indispensable tool for your trial’s success. Following is an out of outline a criteria that could be helpful in finding the right RBM specialist.
-
Can Big Data Rescue Clinical Trials
5/22/2019
Big data and data mining are being leveraged to improve drug development, with huge potential implications in identifying and correcting issues that arise during clinical trials. This article is a quick overview of what big data is and how we look at and define program failures and faltering trials.
-
Not Enrolling Enough? How To Rescue Your Recruitment
5/8/2019
A common issue regarding “faltering” studies – studies that are not satisfying their time, cost, and quality parameters – is poor recruitment. Recruitment issues can delay deadlines and jeopardize the drug’s ultimate approval, if left unresolved. If your study is struggling because of recruitment issues, here are some considerations that can be used to rescue your clinical trial.
-
Is Your Clinical Trial In Need Of A Rescue?
5/8/2019
Don’t assume your clinical trial will survive endless change orders, extended deadlines, cost overruns, and missed objectives. Recognizing early warning signs that your trial is in trouble, and taking quick decisive action, can often get studies back on track. Improving operations can solve most failure risk factors, thus increasing the odds of success.
-
Is Gut Microbiome Behind Our Next Breakthrough Therapy?
5/6/2019
We’re now only beginning to understand how the microbiome influences our health and behavior and vice versa. As we learn more about its connection to a host of diseases and disorders, we expect to see specific bacterial molecules as potential druggable targets.
-
When Virtual Trials Are Not The Answer
5/6/2019
When used successfully, the virtual clinical trial model promises to enroll more patients faster, improve patient retention, and reduce costs. For all their perceived advantages, a virtual model doesn’t suit all studies. Read some challenges of virtual trials as well as when they do and do not work.